Details of MHC II Antigen Processing and Presentation

Antigen processing and presentation through Major Histocompatibility Complex (MHC) Class II molecules are fundamental processes in adaptive immunity, facilitating the detection and elimination of extracellular pathogens and foreign antigens. This intricate pathway involves several steps that ensure the efficient presentation of exogenous peptides derived from engulfed antigens to helper T lymphocytes (CD4+ T cells), thereby orchestrating appropriate immune responses. From the initial phagocytosis of the antigenic protein to the transport of peptide-loaded MHC Class II molecules to the plasma membrane, each stage of antigen processing is carefully regulated.

The process commences with the phagocytosis of extracellular material containing the antigenic protein by antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells. Within the phagosome, the engulfed antigens undergo proteolytic degradation by the immunoproteasome—a specialized form of the proteasome complex that generates peptide fragments suitable for MHC Class II presentation. The immunoproteasome selectively cleaves proteins into shorter peptide fragments, typically ranging from 13 to 25 amino acids in length, ensuring the generation of antigenic peptides compatible with MHC Class II binding.

Following proteasomal degradation, the peptide fragments are loaded onto MHC Class II molecules within the endosomal or phagosomal compartments of the APC. MHC Class II molecules are synthesized in the endoplasmic reticulum (ER) and subsequently transported to endosomes or phagosomes via the Golgi apparatus. Within these compartments, MHC Class II molecules associate with a chaperone protein called the invariant chain (Ii), which prevents premature peptide binding and guides the MHC Class II molecules to specialized antigen-processing compartments. As the antigen is degraded, a fragment of Ii known as CLIP (class II-associated invariant chain peptide) remains bound to the MHC Class II molecule, temporarily blocking the peptide-binding groove.

To enable peptide loading, CLIP must be displaced from the peptide-binding groove of MHC Class II molecules. This process is facilitated by the action of a non-classical MHC Class II molecule called HLA-DM (in humans), or H2-M (in mice), which catalyzes the exchange of CLIP with the antigenic peptide. Once loaded with antigenic peptides, the peptide-MHC Class II complexes are stabilized and transported to the plasma membrane for presentation to CD4+ T cells.

The transport of peptide-loaded MHC Class II molecules to the plasma membrane involves the fusion of transport vesicles containing the peptide-MHC Class II complexes with the plasma membrane. This process is mediated by cytoskeletal elements and molecular motors that facilitate the movement of vesicles along microtubules. Upon reaching the cell surface, the peptide-loaded MHC Class II molecules are displayed for surveillance by CD4+ T cells, which possess T cell receptors (TCRs) capable of recognizing specific peptide-MHC Class II complexes.

Recognition of a peptide-MHC Class II complex by a CD4+ T cell leads to T cell activation, initiating a cascade of immune responses tailored to combat the invading pathogen or foreign antigen. CD4+ T cells serve as central regulators of the immune response, coordinating the activation of other immune cells and facilitating the generation of antigen-specific effector responses.

In conclusion, antigen processing and presentation via MHC Class II molecules involve a sequence of intricately regulated steps, beginning with the phagocytosis of the antigenic protein and culminating in the transport of peptide-loaded MHC Class II molecules to the plasma membrane. This process enables the immune system to detect and respond to extracellular pathogens and foreign antigens, thereby safeguarding the host against infectious diseases and maintaining immune homeostasis. Understanding the mechanisms underlying antigen processing and presentation via MHC Class II molecules is essential for elucidating immune responses and developing effective strategies for immunotherapy and vaccine development.

Next Topic: Antigen Delivery to Lymph Nodes by Dendritic Cells

Source: ChatGPT response prompted and edited by Joel Graff.

• Immunology (Table of Contents for Entire Course – FREE!)
  • Other Content for Unit 3: Professional Antigen Presenting Cells